InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Lundberg Sven Ante, Chief Executive Officer. Insider active across 1 company, notably Merus N.V.. In total, 9 reports have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €465k. Activity tracked since 2 August 2021. The latest transaction was disclosed on 17 April 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
3,797 shares@ US$12.543.5% of flowCommon SharesSEC:0000950170-25-056278:0
40,601 shares0Common SharesSEC:0000950170-25-024836:0
16,372 shares@ US$24.4332.6% of flowCommon SharesSEC:0000950170-25-022520:0
14,706 shares@ US$14.377218.3% of flowCommon SharesSEC:0001209191-22-055466:0
Ideal exit: 31 Jul 2023 (T+270)
5,826 shares@ US$22.924511.4% of flowCommon StockSEC:0001209191-22-047168:0
Ideal exit: 19 May 2023 (T+270)
704 shares@ US$22.99281.4% of flowCommon StockSEC:0001209191-22-046994:0
Ideal exit: 16 May 2023 (T+270)
4,340 shares@ US$22.96888.4% of flowCommon SharesSEC:0001209191-22-042002:0
Ideal exit: 8 Apr 2023 (T+270)
12,627 shares@ US$13.5250.0% of flowCommon SharesSEC:0001209191-21-049593:0
12,627 shares@ US$13.5212.2% of flowCommon SharesSEC:0001209191-21-049593
9 of 9 declarations
About Lundberg Sven Ante
Sven Ante Lundberg is President, CEO, and CFO of Merus N.V. He oversees the operations and strategy of the company. With a strong background in the biopharmaceutical sector, Sven plays a key role in developing innovative treatments and in the growth of the company.
